Literature DB >> 19046721

Systemic polyarteritis nodosa following hepatitis B vaccination.

Jozélio Freire de Carvalho1, Rosa Maria Rodrigues Pereira, Yehuda Shoenfeld.   

Abstract

The authors report a patient who developed systemic polyarteritis nodosa two months after hepatitis B vaccination and review the literature concerning this vaccination and the development of autoimmune conditions, mainly vasculitis. A 14-year-old boy who had no relevant previous history and who was not taking any drugs presented with a livedo reticularis, fever, loss of weight, testicular pain, and paresthesias two months after receiving the third dose of a hepatitis B vaccination. Inflammatory parameters (ESR and CRP) were high. The patient met the ACR diagnostic criteria for polyarteritis nodosa. He received corticosteroids and immunosuppressants and showed improvement. After reviewing the 27 cases of vasculitis after hepatitis B vaccination reported in the current literature, the authors suggest that, in some cases, vaccination may be the triggering factor for vasculitis in individuals with a genetic predisposition. Physicians should be aware of this possible association.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19046721     DOI: 10.1016/j.ejim.2007.06.035

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  5 in total

1.  Systemic vasculitis: a dual diagnosis?

Authors:  Eliza Gil; Pamela Lutalo; David D'Cruz
Journal:  BMJ Case Rep       Date:  2011-12-02

2.  [Vaccination in adult patients with chronic inflammatory rheumatic diseases].

Authors:  S Goldacker; A M Gause; K Warnatz
Journal:  Z Rheumatol       Date:  2013-09       Impact factor: 1.372

Review 3.  Vaccines, adjuvants and autoimmunity.

Authors:  Luísa Eça Guimarães; Britain Baker; Carlo Perricone; Yehuda Shoenfeld
Journal:  Pharmacol Res       Date:  2015-08-12       Impact factor: 7.658

4.  Video Q&A: what is ASIA? An interview with Yehuda Shoenfeld.

Authors:  Yehuda Shoenfeld
Journal:  BMC Med       Date:  2013-05-01       Impact factor: 8.775

Review 5.  Frequently asked questions on seven rare adverse events following immunization.

Authors:  G L D'alò; E Zorzoli; A Capanna; G Gervasi; E Terracciano; L Zaratti; E Franco
Journal:  J Prev Med Hyg       Date:  2017-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.